Article info
Liver
Original research
Major variation in hepatocellular carcinoma treatment and outcomes in England: a retrospective cohort study
- Correspondence to Ayman Nassar, Bristol Myers Squibb Pharmaceuticals Ltd, Uxbridge, UK; ayman.nassar{at}bms.com
Citation
Major variation in hepatocellular carcinoma treatment and outcomes in England: a retrospective cohort study
Publication history
- Received February 16, 2022
- Accepted April 22, 2022
- First published May 9, 2022.
Online issue publication
January 23, 2024
Article Versions
- Previous version (7 December 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.